MarginsXMarginsX
Home › Markets › Consumer Staples › RDGT

Ridgetech Inc. (RDGT)

RDGT trades on Nasdaq in Consumer Staples, Retail-Drug Stores and Proprietary Stores. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$1.01
-4.72% on the day
Market cap
$3.7M
Nano cap
Revenue · 2025
$132.2M
+10.2% on 2024
Net income · 2025
-$1.3M
-0.9% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 20-F (us-gaap:Revenues), fiscal year ended 2026-03-31, https://www.sec.gov/Archives/edgar/data/1856084/000121390026083638/0001213900-26-083638-index.htm. Net income: SEC 20-F (us-gaap:NetIncomeLoss), fiscal year ended 2026-03-31.

Profile

FieldValue
TickerRDGT on Nasdaq
SectorConsumer Staples
IndustryRetail-Drug Stores and Proprietary Stores
CountryChina
IPO yearNot reported by the screener
SEC CIK0001856084
SEC industry codeRetail-Drug Stores and Proprietary Stores
Incorporated inCayman Islands

Financials · 2025

LineValue
Revenue$132.2M
Net income-$1.3M
Operating income-$1.9M
Net margin-0.9%
Operating margin-1.4%
Revenue growth+10.2%
Cash$17.9M
Total assets$69.0M
P/E (computed)Net income was not positive
P/S (computed)0.0×

Warning signs

Cash runway
154.1 months
$17.9M cash at March 31, 2026
Share count, 1 year
+340866.6%
2025-03-31 to 2026-03-31 · +1684792.5% over 3 years
Going-concern doubt
No
20-F filed July 31, 2026
Insider net buying, 12 months
$46K
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.20-F 2026-07-31
Cash and burn$17.9M cash; operating cash flow -$348K a quarter.Report 2026-03-31
Shares outstandingNo cover-page share count in XBRLCover page 2026-03-31
Reverse splits, 3 years2; latest 1-for-150 on 2026-04-08Source 2026-04-08
Shelf and offerings, 12 months1 S-3/F-3 shelf filings; 2 424B5 takedowns, 2 at the marketLatest 2026-07-29
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorYCM CPA INC., Irvine, California, United StatesPCAOB Form AP 2026-08-11
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $161K, sold $116K on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Annual results

Fiscal yearRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
FY 2026
2026-03-31
$132.2M-$1.3M-$1.4M$17.9M$23K$132.2M20-F 2026-07-31
FY 2025
2025-03-31
$120.0M$10.2M$1.2M$12.8M$10.4M$120.0M20-F 2026-07-31
FY 2024
2024-03-31
$124.0M-$4.2M-$3.2M$2.3M$6.9M$124.0M20-F 2026-07-31
FY 2023
2023-03-31
$120.2M-$21.1M-$3.3M$18.8M$29.3M$120.2M20-F 2025-07-28
FY 2022
2022-03-31
$164.4M-$3.2M-$5.4M$18.5M$36.1M$164.4M20-F 2024-07-30
FY 2021
2021-03-31
$133.1M-$8.1M-$62K$22.0M$2.7M$133.1M20-F 2023-06-15
FY 2020
2020-03-31
$117.3M-$5.8M-$6.9M$31.0MNo debt tags$117.3M20-F 2022-07-28

From SEC XBRL company facts (annual reports only: 20-F or 40-F). Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document
PROSPECTUS SUPPLEMENT
424B52026-07-29
Latest annual report
ANNUAL REPORT
20-F2026-07-31
Latest quarterly / interim
REPORT OF FOREIGN PRIVATE ISSUER
6-K2026-11-06

Source: SEC EDGAR submissions feed, 132 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week+6.0%
1 month+23.3%
3 months+20.5%
Year to date-99.8%
1 year-99.8%
From 52-week high-99.9%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Retail-Drug Stores and Proprietary Stores

TickerCompanyPriceDayMarket cap
PETSPetMed Express Inc.$0.8977-4.52%$20.0M
YI111 Inc.$2.84-0.35%$25.0M
GRDNGuardian Pharmacy Services Inc.$49.43-0.18%$3.1B
CVSCVS Health Corporation$88.59-0.85%$113.3B

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier